Total Payments
$7,509
2024 Payments
$164.73
Companies
32
Transactions
257
Medicare Patients
11,364
Medicare Billing
$989,072
Payment Breakdown by Category
Food & Beverage$5,705 (76.0%)
Research$1,605 (21.4%)
Education$198.61 (2.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,705 | 250 | 76.0% |
| Unspecified | $1,605 | 1 | 21.4% |
| Education | $198.61 | 6 | 2.6% |
Payments by Type
General
$5,904
256 transactions
Research
$1,605
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,718 | 6 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $1,002 | 49 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $922.07 | 39 | $0 (2022) |
| Amgen Inc. | $629.80 | 20 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $431.95 | 18 | $0 (2022) |
| Gilead Sciences, Inc. | $296.90 | 16 | $0 (2018) |
| CHIESI USA, INC. | $230.75 | 12 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $229.27 | 12 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $228.34 | 10 | $0 (2021) |
| BOSTON SCIENTIFIC CORPORATION | $206.06 | 7 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $164.73 | 7 | Novartis Pharmaceuticals Corporation ($48.62) |
| 2023 | $57.69 | 3 | Novartis Pharmaceuticals Corporation ($33.95) |
| 2022 | $281.37 | 8 | E.R. Squibb & Sons, L.L.C. ($135.79) |
| 2021 | $390.86 | 9 | Janssen Pharmaceuticals, Inc ($173.07) |
| 2020 | $1,762 | 9 | Abbott Laboratories ($1,605) |
| 2019 | $1,083 | 40 | Amgen Inc. ($229.01) |
| 2018 | $1,988 | 99 | Novartis Pharmaceuticals Corporation ($330.61) |
| 2017 | $1,780 | 82 | Novartis Pharmaceuticals Corporation ($468.14) |
All Payment Transactions
257 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/06/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $33.32 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 07/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/29/2024 | LANTHEUS MEDICAL IMAGING, INC. | DEFINITY (Drug) | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: CONTRAST AGENT | ||||||
| 04/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/08/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Diabetes | ||||||
| 03/26/2024 | Terumo Medical Corporation | GLIDEWIRE (Device) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: LESION ACCESS | ||||||
| 01/11/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Not Applicable | ||||||
| 05/11/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Cardio-renal | ||||||
| 05/04/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/19/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/27/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $113.22 | General |
| Category: Cardiovascular | ||||||
| 10/11/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $13.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/26/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/01/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $34.56 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/25/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/22/2022 | Lantheus Medical Imaging, Inc. | DEFINITY (Drug) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: CONTRAST AGENT | ||||||
| 03/03/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.57 | General |
| Category: Cardiovascular | ||||||
| 01/14/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $38.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/14/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $173.07 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/14/2021 | Philips Electronics North America Corporation | (8333) IGT D Coronary (Device) | Food and Beverage | Cash or cash equivalent | $22.49 | General |
| Category: Medical Device | ||||||
| 10/13/2021 | Medtronic, Inc. | Arctic Front (Device) | Food and Beverage | In-kind items and services | $33.82 | General |
| Category: Ablation | ||||||
| 09/23/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.37 | General |
| Category: Cardiovascular | ||||||
| 08/26/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/29/2021 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological), EVKEEZA | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 07/08/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $32.10 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| OPTIS Next Summative Study | Abbott Laboratories | $1,605 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 2,608 | 3,653 | $1.1M | $236,157 |
| 2022 | 28 | 2,638 | 3,728 | $1.0M | $236,184 |
| 2021 | 34 | 3,137 | 4,413 | $951,344 | $291,224 |
| 2020 | 39 | 2,981 | 3,779 | $781,310 | $225,507 |
Total Patients
11,364
Total Services
15,573
Medicare Billing
$989,072
Procedure Codes
135
All Medicare Procedures & Services
135 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 520 | 821 | $435,048 | $113,746 | 26.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 98 | 98 | $65,288 | $16,911 | 25.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 102 | 109 | $41,537 | $11,110 | 26.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 569 | 934 | $49,914 | $10,913 | 21.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 172 | 175 | $111,249 | $9,551 | 8.6% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 17 | 19 | $38,323 | $9,128 | 23.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 40 | 40 | $25,922 | $7,516 | 29.0% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 36 | 37 | $128,040 | $7,317 | 5.7% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 35 | 36 | $23,256 | $6,283 | 27.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 58 | 91 | $18,984 | $5,576 | 29.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 50 | 53 | $21,176 | $5,050 | 23.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 29 | 30 | $17,422 | $4,313 | 24.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 36 | $10,857 | $3,627 | 33.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 382 | 492 | $13,776 | $3,313 | 24.1% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 15 | 15 | $12,720 | $3,203 | 25.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 22 | 22 | $14,984 | $2,868 | 19.1% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 31 | 32 | $11,088 | $2,728 | 24.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 14 | 14 | $17,906 | $2,119 | 11.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 140 | 149 | $3,990 | $1,866 | 46.8% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 11 | 11 | $33,011 | $1,657 | 5.0% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 16 | 20 | $9,524 | $1,590 | 16.7% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 45 | 46 | $4,727 | $992.68 | 21.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 14 | 39 | $2,741 | $825.63 | 30.1% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 11 | 11 | $3,158 | $812.19 | 25.7% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 14 | 75 | $3,000 | $751.50 | 25.1% |
About Dr. Christopher Gange, MD
Dr. Christopher Gange, MD is a Cardiovascular Disease healthcare provider based in Framingham, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1821143736.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Gange, MD has received a total of $7,509 in payments from pharmaceutical and medical device companies, with $164.73 received in 2024. These payments were reported across 257 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,705).
As a Medicare-enrolled provider, Gange has provided services to 11,364 Medicare beneficiaries, totaling 15,573 services with total Medicare billing of $989,072. Data is available for 4 years (2020–2023), covering 135 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Framingham, MA
- Active Since 01/24/2007
- Last Updated 05/31/2010
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1821143736
Products in Payments
- Optis Coronary Imaging System (Device) $1,605
- ENTRESTO (Drug) $953.03
- XARELTO (Drug) $922.07
- ELIQUIS (Drug) $365.82
- Corlanor (Drug) $346.58
- Repatha (Biological) $283.22
- PRALUENT (Drug) $197.43
- BRILINTA (Drug) $159.22
- WATCHMAN DEVICE (Device) $154.04
- KENGREAL (Drug) $136.86
- PRADAXA (Drug) $133.27
- Impella (Device) $129.65
- Arctic Front (Device) $125.71
- PRALUENT (Biological) $115.52
- CAMZYOS (Drug) $113.22
- PRALUENT ALIROCUMAB INJECTION (Biological) $112.82
- LifeVest (Device) $105.32
- NEXLETOL (Drug) $90.36
- Definity (Drug) $86.02
- CHANTIX (Drug) $83.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Framingham
Dr. Patrick Blomberg, Md, MD
Cardiovascular Disease — Payments: $6,797
Cardiovascular Disease $6,797
Dr. James Alderman, Md, MD
Cardiovascular Disease — Payments: $5,212
Cardiovascular Disease $5,212
Dr. Eric Davidson, Md, MD
Cardiovascular Disease — Payments: $4,062
Cardiovascular Disease $4,062
Dr. Donald Love, Md, MD
Cardiovascular Disease — Payments: $3,562
Cardiovascular Disease $3,562
George Kinzfogl, Md, MD
Cardiovascular Disease — Payments: $2,609
Cardiovascular Disease $2,609
Vikas Desai, Md, MD
Cardiovascular Disease — Payments: $2,145
Cardiovascular Disease $2,145